IE45454L - Cns-active compositions - Google Patents
Cns-active compositionsInfo
- Publication number
- IE45454L IE45454L IE771509A IE150977A IE45454L IE 45454 L IE45454 L IE 45454L IE 771509 A IE771509 A IE 771509A IE 150977 A IE150977 A IE 150977A IE 45454 L IE45454 L IE 45454L
- Authority
- IE
- Ireland
- Prior art keywords
- compound
- cns
- active compositions
- gabamimetic
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
PHARMACEUTICAL COMPOSITIONS HAVING AN ACTION ON THE CENTRAL NERVOUS SYSTEM The specification discloses pharmaceutical compositions, having an action on the central nervous system, containing a gabamimetic compound and a neuroleptic compound. The gabamimetic compound has the formula and the neuroleptic compound has the formula The compositions of the invention are medicaments which can be used in human therapy in the psychiatric field and, in particular, in the treatment of psychosis.
[CA1077846A]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7622045A FR2358881A1 (en) | 1976-07-20 | 1976-07-20 | Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia |
FR7719390A FR2453643A2 (en) | 1977-06-24 | 1977-06-24 | PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM |
Publications (2)
Publication Number | Publication Date |
---|---|
IE45454L true IE45454L (en) | 1978-01-20 |
IE45454B1 IE45454B1 (en) | 1982-08-25 |
Family
ID=26219550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1509/77A IE45454B1 (en) | 1976-07-20 | 1977-07-19 | Pharmaceutical compositions having an action on the central nervous system |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS5326327A (en) |
AU (1) | AU508753B2 (en) |
CA (1) | CA1077846A (en) |
DE (1) | DE2732614A1 (en) |
GB (1) | GB1556567A (en) |
IE (1) | IE45454B1 (en) |
IL (1) | IL52550A (en) |
LU (1) | LU77796A1 (en) |
NL (1) | NL7708055A (en) |
NZ (1) | NZ184666A (en) |
SE (1) | SE7708349L (en) |
-
1977
- 1977-07-18 IL IL52550A patent/IL52550A/en unknown
- 1977-07-18 NZ NZ184666A patent/NZ184666A/en unknown
- 1977-07-19 CA CA283,049A patent/CA1077846A/en not_active Expired
- 1977-07-19 DE DE19772732614 patent/DE2732614A1/en not_active Withdrawn
- 1977-07-19 SE SE7708349A patent/SE7708349L/en not_active Application Discontinuation
- 1977-07-19 GB GB30355/77A patent/GB1556567A/en not_active Expired
- 1977-07-19 LU LU77796A patent/LU77796A1/xx unknown
- 1977-07-19 IE IE1509/77A patent/IE45454B1/en unknown
- 1977-07-19 AU AU27151/77A patent/AU508753B2/en not_active Expired
- 1977-07-20 JP JP8785277A patent/JPS5326327A/en active Pending
- 1977-07-20 NL NL7708055A patent/NL7708055A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
LU77796A1 (en) | 1977-10-25 |
NL7708055A (en) | 1978-01-24 |
IL52550A0 (en) | 1977-10-31 |
IL52550A (en) | 1981-03-31 |
SE7708349L (en) | 1978-01-21 |
DE2732614A1 (en) | 1978-01-26 |
CA1077846A (en) | 1980-05-20 |
JPS5326327A (en) | 1978-03-11 |
AU508753B2 (en) | 1980-04-03 |
IE45454B1 (en) | 1982-08-25 |
GB1556567A (en) | 1979-11-28 |
NZ184666A (en) | 1980-04-28 |
AU2715177A (en) | 1979-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7951082A (en) | I.v. therapy or hyperalimentation catheter | |
DE3070189D1 (en) | Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it | |
AU544252B2 (en) | Lipometabolism disorders medicaments | |
IL112029A (en) | Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin | |
UA32543C2 (en) | Aryl acetamides having analgetic action, a PROCESS for preparation thereof, pharmaceutical composition and a PROCESS for preparation thereof | |
IT7830192A0 (en) | NITRO-SUBSTITUTED 1,4-DI-HYDRO-PYRIDINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS. | |
GR3023638T3 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
NO863313L (en) | MIXTURE TREATMENT DEVICE. | |
IL59425A0 (en) | N-substituted aziridine-2-carboxylic acid derivatives,processes for preparation thereof and pharmaceutical compositins containing the same | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
AU516563B2 (en) | Therapeutic treatment | |
AU542902B2 (en) | Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them | |
JPS5252112A (en) | Spheroidizing treatment | |
AU8732182A (en) | Pharmaceutical compositions for the treatment of skin | |
IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
DK0719276T3 (en) | Estradiol esters with strong oral action as well as pharmaceutical preparations containing them | |
AU1312276A (en) | Treatment for swine bysentery | |
NZ184634A (en) | N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions | |
IE45454L (en) | Cns-active compositions | |
IT8320023A0 (en) | CARBACICLINES, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES. | |
JPS568398A (en) | Bis*44demethoxidoonorbicin*dihydrazone derivative and its salt acceptable as medicine | |
AU1634776A (en) | N-SUBSTITUTED c C AMINO METHYL-4HYDROXY 1, 3 BENZENE DIMETHANOI | |
JPS5775969A (en) | N-(1-aryl-2-pyrrolidinylmethyl)-2-methoxy-4- amino-5-methylsulfamoylbenzamide, manufacture and analgesic thereof as effective ingredient | |
ZA928127B (en) | Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation. | |
NZ182193A (en) | Derivatives of the pregnancyspecific -glycoprotein,and immunising agents |